Clear cell sarcoma of the kidney - A review of 351 cases from the NationalWilms Tumor Study Group Pathology Center

Citation
P. Argani et al., Clear cell sarcoma of the kidney - A review of 351 cases from the NationalWilms Tumor Study Group Pathology Center, AM J SURG P, 24(1), 2000, pp. 4-18
Citations number
33
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Journal title
AMERICAN JOURNAL OF SURGICAL PATHOLOGY
ISSN journal
01475185 → ACNP
Volume
24
Issue
1
Year of publication
2000
Pages
4 - 18
Database
ISI
SICI code
0147-5185(200001)24:1<4:CCSOTK>2.0.ZU;2-V
Abstract
We reviewed 351 cases of clear cell sarcoma of the kidney (CCSK), including 182 cases entered on National Wilms Tumor Study Group (NWTSG) trials 1-4 f or which clinical follow-up information was available. Tumors were restaged using NWTS 5 criteria. Mean age at diagnosis in the NWTS group was 36 mont hs with a range of 2 months to 14 years. The male to female ratio was 2:1. Typical gross features included large size (mean diameter 11.3 cm), a mucoi d texture, foci of necrosis, and prominent cyst formation. Nine major histo logic patterns were identified (classic, myxoid, sclerosing, cellular, epit helioid, palisading, spindle, storiform, and anaplastic); virtually all tum ors contained multiple patterns that blended with one another. Immunohistoc hemical stains were performed on 45 cases; only vimentin was consistently i mmunoreactive, Consistently negative results with other antibodies helped e xclude other tumors in the differential diagnosis; all CCSKs were cytokerat in-negative, including epithelioid tumors that mimicked Wilms tumor, and MI C2-negative, including cellular tumors that mimicked primitive neuroectoder mal tumor. The p53 gene product was rarely overexpressed in non-anaplastic CCSKs, but strikingly overexpressed in two of three anaplastic CCSKs. Overa ll survival was 69%. Multivariate analysis revealed four independent progno stic factors for survival: treatment with doxorubicin, stage, age at diagno sis, and tumor necrosis, Of note, stage 1 patients had a remarkable 98% sur vival rate. No other histologic or clinical variable independently correlat ed with survival.